Atria Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
23,501
+219
| +0.9% | +$97.5K | 0.12% | 181 |
|
|
2025
Q1 | $11.3M | Buy |
23,282
+4,684
| +25% | +$2.27M | 0.14% | 160 |
|
|
2024
Q4 | $7.49M | Sell |
18,598
-1,527
| -8% | -$615K | 0.09% | 246 |
|
|
2024
Q3 | $9.36M | Sell |
20,125
-1,564
| -7% | -$727K | 0.12% | 204 |
|
|
2024
Q2 | $10.2M | Buy |
21,689
+1,168
| +6% | +$547K | 0.13% | 168 |
|
|
2024
Q1 | $8.58M | Sell |
20,521
-847
| -4% | -$354K | 0.12% | 196 |
|
|
2023
Q4 | $8.69M | Sell |
21,368
-1,023
| -5% | -$416K | 0.13% | 182 |
|
|
2023
Q3 | $7.79M | Sell |
22,391
-14
| -0.1% | -$4.87K | 0.14% | 180 |
|
|
2023
Q2 | $7.88M | Buy |
22,405
+1,082
| +5% | +$381K | 0.14% | 168 |
|
|
2023
Q1 | $6.72M | Sell |
21,323
-6,321
| -23% | -$1.99M | 0.13% | 196 |
|
|
2022
Q4 | $7.98M | Sell |
27,644
-105
| -0.4% | -$30.3K | 0.16% | 153 |
|
|
2022
Q3 | $8.03M | Buy |
27,749
+2,997
| +12% | +$868K | 0.18% | 138 |
|
|
2022
Q2 | $6.98M | Sell |
24,752
-4,758
| -16% | -$1.34M | 0.15% | 172 |
|
|
2022
Q1 | $7.7M | Buy |
29,510
+2,890
| +11% | +$754K | 0.13% | 180 |
|
|
2021
Q4 | $5.85M | Buy |
26,620
+1,433
| +6% | +$315K | 0.1% | 234 |
|
|
2021
Q3 | $4.57M | Buy |
25,187
+14,721
| +141% | +$2.67M | 0.08% | 279 |
|
|
2021
Q2 | $2.11M | Buy |
10,466
+2,243
| +27% | +$452K | 0.04% | 478 |
|
|
2021
Q1 | $1.77M | Sell |
8,223
-1,773
| -18% | -$381K | 0.04% | 491 |
|
|
2020
Q4 | $2.36M | Buy |
9,996
+608
| +6% | +$144K | 0.06% | 376 |
|
|
2020
Q3 | $2.56M | Sell |
9,388
-13,072
| -58% | -$3.56M | 0.08% | 278 |
|
|
2020
Q2 | $6.52M | Buy |
22,460
+15,172
| +208% | +$4.4M | 0.22% | 110 |
|
|
2020
Q1 | $1.73M | Buy |
7,288
+399
| +6% | +$94.9K | 0.13% | 153 |
|
|
2019
Q4 | $1.51M | Buy |
6,889
+3,923
| +132% | +$859K | 0.04% | 398 |
|
|
2019
Q3 | $502K | Sell |
2,966
-489
| -14% | -$82.8K | 0.02% | 576 |
|
|
2019
Q2 | $625K | Sell |
3,455
-1,798
| -34% | -$325K | 0.02% | 518 |
|
|
2019
Q1 | $966K | Sell |
5,253
-204
| -4% | -$37.5K | 0.04% | 369 |
|
|
2018
Q4 | $904K | Sell |
5,457
-625
| -10% | -$104K | 0.04% | 326 |
|
|
2018
Q3 | $1.17M | Buy |
6,082
+2,168
| +55% | +$418K | 0.05% | 356 |
|
|
2018
Q2 | $665K | Buy |
3,914
+65
| +2% | +$11K | 0.03% | 485 |
|
|
2018
Q1 | $627K | Sell |
3,849
-916
| -19% | -$149K | 0.03% | 463 |
|
|
2017
Q4 | $714K | Buy |
4,765
+350
| +8% | +$52.4K | 0.04% | 409 |
|
|
2017
Q3 | $671K | Buy |
4,415
+968
| +28% | +$147K | 0.04% | 395 |
|
|
2017
Q2 | $444K | Buy |
+3,447
| New | +$444K | 0.03% | 455 |
|